Orencia (abatacept) - BMS
Nulojix (belatacept) - BMS
Abatacept as maintenance therapy in kidney transplantation: a retrospective comparative study. (PubMed, Transpl Int) - Sep 30, 2026 - "These findings, which warrant confirmation in larger studies, suggest that abatacept is associated with acceptable safety outcomes relative to belatacept. Abatacept may thererefore be considered a potential alternative in selected situations, including drug shortage, limited venous access, pregnancy or the need for greater treatment autonomy." 
Clinical • Journal • Retrospective data • Infectious Disease • Rheumatology • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42807268
 
Alba Atenza; Anne-Elisabeth Heng; Aurélien Tiple; Carole Philipponnet; Charlotte Uro-Coste; Claire Chatron; Clarisse Grèze; Cyril Garrouste; Inés Ramos; Jimmy Garraud; Marine Freist; Paul Rouzaire
 
Sep 30, 2026
 
Prev Next